scholarly journals PD44-08 PENILE PROSTHESIS IMPLEMENTATION WHILE ON ANTICOAGULANT THERAPY: A RETROSPECTIVE STUDY

2019 ◽  
Vol 201 (Supplement 4) ◽  
Author(s):  
Alfredo Suarez-Sarmiento* ◽  
Matthew Brennan ◽  
Alfredo Suarez-Sarmiento ◽  
Paul Perito
2019 ◽  
Vol 16 (4) ◽  
pp. S15-S16
Author(s):  
A. Suarez-Sarmiento ◽  
P. Perito ◽  
M. Brennan ◽  
A. Suarez-Sarmiento

2017 ◽  
Vol 5 (1) ◽  
Author(s):  
Takahiro Hirayama ◽  
Nobuyuki Nosaka ◽  
Yasumasa Okawa ◽  
Soichiro Ushio ◽  
Yoshihisa Kitamura ◽  
...  

2008 ◽  
Vol 2008 ◽  
pp. 1-5 ◽  
Author(s):  
Marco Grasso ◽  
Caterina Lania ◽  
Flavio Fortuna ◽  
Salvatore Blanco ◽  
Igor Piacentini

The aim of this retrospective study is to evaluate the long-term followup of soft penile SSDA prosthesis, without plaque surgery in the treatment of Peyronie's disease. This study included 12 men with Peyronie's disease who underwent placement of a penile prosthesis. All patients were followed for at least 6 years. Prosthesis straightened the penile shaft in all cases, restoring patient sexual satisfaction. No operative or postoperative complications occurred, and no reoperations were needed. All patients have undergone further examination with basal and dynamic eco color Doppler. The findings are encouraging as the penis preserves the ability to enhance the tumescence and penile girth. We can conclude that SSDA penile prosthesis is safe and effective in Peyronie's disease.


2001 ◽  
Vol 40 (06) ◽  
pp. 179-186 ◽  
Author(s):  
H. Pohlabeln ◽  
M. Lemb

SummaryPurpose: Conventional planar ventilation/perfusion (V/P)- imaging in those patients suspected of suffering from pulmonary thromboembolism (PTE) is of limited diagnostic value. It is the purpose of this retrospective study to determine whether the use of V/P- SPECT using Technegas might reduce the rate of those diagnostic uncertainties and might lead to better results. Methods: 991 patients (660 female, 331 male, age 18-90, mean 60), referred to our laboratory with suspected PTE, were examined as follows: patients inhaled 37 MBq of Technegas in the supine position and a SPECT-acquisition was started. Following SPECT-completion, 185 MBq 99mTc-MAA was injected intravenously. SPECT was then repeated. Coronal and transverse ventilation and perfusion SPECT-slices were reconstructed and compared section by section. 85 patients underwent control scans by the same technique at a mean interval of 22 months after the original scans. Results: As the SPECT images in almost all cases made a clear match/mismatch decision possible, we categorized all patients as embolic (PTE+) if there was at least one mismatching defect, and as non embolic (PTE-) if there were none. Our results were: PTE +: 178 patients (18%), PTE-: 808 patients (81%), uncertain: 5 patients (0.5%), if 34 triple-match defects are included: 39 patients (3.9%). 46 patients, categorized as PΪE+ underwent a control V/P scan after anticoagulant therapy. In 44 of these patients, PTE was confirmed by the controls. In a control group of 39 PTE- patients, control scans were unchanged in 38 cases. From these observations we can calculate a sensitivity of 96% and a specificity of 97%. Conclusion: We conclude that V/P imaging can be improved significantly by V/P SPECT using Technegas.


2009 ◽  
Vol 8 (4) ◽  
pp. 215
Author(s):  
G. Neyra Lee ◽  
C. Nazir Diuana ◽  
H. Alvarez Nuño ◽  
J.H. Neyra Argote

Sign in / Sign up

Export Citation Format

Share Document